Inflammation and prostate cancer: friends or foe?

Gianluigi Taverna, Elisa Pedretti, Giuseppe Di Caro, Elena Monica Borroni, Federica Marchesi, Fabio Grizzi

Research output: Contribution to journalArticlepeer-review


Introduction: Prostate cancer is the most common non-cutaneous malignancy diagnosed in men. Moving from histological observations since a long time, it has been recognized that innate and adaptive immunity actively participates in the pathogenesis, surveillance, and progression of prostate cancer. Materials and methods: A PubMed and Web of Science databases search was performed for studies providing evidence on the roles of the innate and adaptive immunity during the development and progression of prostate cancer. Conclusions: There are growing evidences that chronic inflammation is involved in the regulation of cellular events in prostate carcinogenesis, including disruption of the immune response and regulation of the tumor microenvironment. This review discusses the role played by the innate and adaptive immune system in the local progression of prostate cancer, and the prognostic information that we can currently understand and exploit.

Original languageEnglish
Pages (from-to)275-286
Number of pages12
JournalInflammation Research
Issue number5
Publication statusPublished - May 1 2015


  • Cancer
  • Chemokines
  • Immunity
  • Prostate

ASJC Scopus subject areas

  • Pharmacology
  • Immunology
  • Medicine(all)


Dive into the research topics of 'Inflammation and prostate cancer: friends or foe?'. Together they form a unique fingerprint.

Cite this